Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India
Identifieur interne : 000452 ( PascalFrancis/Corpus ); précédent : 000451; suivant : 000453Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India
Auteurs : A. S. Kerketta ; B. V. Babu ; B. K. SwainSource :
- Acta tropica [ 0001-706X ] ; 2007.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
The Global Programme to Eliminate Lymphatic Filariasis (GPELF), which includes alleviation of disability and suffering of patients, is implemented primarily in India by primary health care system. The present study assesses the current practices related to lymphoedema care among clinicians of primary healthcare system in three filarial endemic districts of Orissa, India. The results are based on the data obtained through in-depth interviews with 50 clinicians from primary health centres (PHCs) and private clinics located in 22 PHCs sampled from three districts. All clinicians are aware of common as well as atypical manifestations of LF and offered treatment to them. The most commonly dealt complaints are lymphoedema of chronic LF and acute lymphangitis. All the clinicians reported that they prescribed diethylcarbamazine (DEC) for the treatment of patients with acute episodes, and only 50% of them prescribed antibiotics along with DEC. However, there is no uniform pattern either in the dosage of DEC or in the use of antibiotics. In this study, all the clinicians are aware that repeated acute episodes leads to lymphoedema. Majority of clinicians (94%) prescribed DEC to prevent this progression. For reduction of oedema, they offered a variety of treatments and more than half of the clinicians prescribed DEC. The study districts have been covered by the mass drug administration (MDA) of DEC under the GPELF. In order for the GPELF as a whole to prove successful and sustainable, those persons who are already suffering from LF need to be cared for and their suffering is to be relieved. Current practices of clinicians, both at government and private health institutions should be improved. With the revised knowledge that bacterial infections play a key role in the progression of disease, the attitude of clinicians towards the treatment of LF has to be changed.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
|
|---|
Format Inist (serveur)
| NO : | PASCAL 07-0367382 INIST |
|---|---|
| ET : | Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India |
| AU : | KERKETTA (A. S.); BABU (B. V.); SWAIN (B. K.) |
| AF : | Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)/Bhubaneswar 751023, Orissa/Inde (1 aut., 2 aut., 3 aut.) |
| DT : | Publication en série; Niveau analytique |
| SO : | Acta tropica; ISSN 0001-706X; Coden ACTRAQ; Pays-Bas; Da. 2007; Vol. 102; No. 3; Pp. 159-164; Bibl. 1 p.1/4 |
| LA : | Anglais |
| EA : | The Global Programme to Eliminate Lymphatic Filariasis (GPELF), which includes alleviation of disability and suffering of patients, is implemented primarily in India by primary health care system. The present study assesses the current practices related to lymphoedema care among clinicians of primary healthcare system in three filarial endemic districts of Orissa, India. The results are based on the data obtained through in-depth interviews with 50 clinicians from primary health centres (PHCs) and private clinics located in 22 PHCs sampled from three districts. All clinicians are aware of common as well as atypical manifestations of LF and offered treatment to them. The most commonly dealt complaints are lymphoedema of chronic LF and acute lymphangitis. All the clinicians reported that they prescribed diethylcarbamazine (DEC) for the treatment of patients with acute episodes, and only 50% of them prescribed antibiotics along with DEC. However, there is no uniform pattern either in the dosage of DEC or in the use of antibiotics. In this study, all the clinicians are aware that repeated acute episodes leads to lymphoedema. Majority of clinicians (94%) prescribed DEC to prevent this progression. For reduction of oedema, they offered a variety of treatments and more than half of the clinicians prescribed DEC. The study districts have been covered by the mass drug administration (MDA) of DEC under the GPELF. In order for the GPELF as a whole to prove successful and sustainable, those persons who are already suffering from LF need to be cared for and their suffering is to be relieved. Current practices of clinicians, both at government and private health institutions should be improved. With the revised knowledge that bacterial infections play a key role in the progression of disease, the attitude of clinicians towards the treatment of LF has to be changed. |
| CC : | 002B01; 002B12B04; 002B05E03B4D |
| FD : | Lymphoedème; Filariose lymphatique; Lymphangite; Adénopathie; Pratique professionnelle; Traitement; Orissa; Médecine tropicale |
| FG : | Nématodose; Helminthiase; Parasitose; Infection; Inde; Asie; Appareil circulatoire pathologie; Lymphatique pathologie |
| ED : | Lymphedema; Lymphatic filariasis; Lymphangitis; Adenopathy; Professional practice; Treatment; Orissa; Tropical medicine |
| EG : | Nematode disease; Helminthiasis; Parasitosis; Infection; India; Asia; Cardiovascular disease; Lymphatic vessel disease |
| SD : | Linfedema; Filariasis linfática; Linfangitis; Adenopatía; Práctica profesional; Tratamiento; Orisa; Medicina tropical |
| LO : | INIST-3165.354000161628780030 |
| ID : | 07-0367382 |
Links to Exploration step
Pascal:07-0367382Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India</title><author><name sortKey="Kerketta, A S" sort="Kerketta, A S" uniqKey="Kerketta A" first="A. S." last="Kerketta">A. S. Kerketta</name><affiliation><inist:fA14 i1="01"><s1>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1><s2>Bhubaneswar 751023, Orissa</s2><s3>IND</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Babu, B V" sort="Babu, B V" uniqKey="Babu B" first="B. V." last="Babu">B. V. Babu</name><affiliation><inist:fA14 i1="01"><s1>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1><s2>Bhubaneswar 751023, Orissa</s2><s3>IND</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Swain, B K" sort="Swain, B K" uniqKey="Swain B" first="B. K." last="Swain">B. K. Swain</name><affiliation><inist:fA14 i1="01"><s1>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1><s2>Bhubaneswar 751023, Orissa</s2><s3>IND</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">07-0367382</idno><date when="2007">2007</date><idno type="stanalyst">PASCAL 07-0367382 INIST</idno><idno type="RBID">Pascal:07-0367382</idno><idno type="wicri:Area/PascalFrancis/Corpus">000452</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India</title><author><name sortKey="Kerketta, A S" sort="Kerketta, A S" uniqKey="Kerketta A" first="A. S." last="Kerketta">A. S. Kerketta</name><affiliation><inist:fA14 i1="01"><s1>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1><s2>Bhubaneswar 751023, Orissa</s2><s3>IND</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Babu, B V" sort="Babu, B V" uniqKey="Babu B" first="B. V." last="Babu">B. V. Babu</name><affiliation><inist:fA14 i1="01"><s1>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1><s2>Bhubaneswar 751023, Orissa</s2><s3>IND</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Swain, B K" sort="Swain, B K" uniqKey="Swain B" first="B. K." last="Swain">B. K. Swain</name><affiliation><inist:fA14 i1="01"><s1>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1><s2>Bhubaneswar 751023, Orissa</s2><s3>IND</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></inist:fA14></affiliation></author></analytic><series><title level="j" type="main">Acta tropica</title><title level="j" type="abbreviated">Acta trop.</title><idno type="ISSN">0001-706X</idno><imprint><date when="2007">2007</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Acta tropica</title><title level="j" type="abbreviated">Acta trop.</title><idno type="ISSN">0001-706X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenopathy</term><term>Lymphangitis</term><term>Lymphatic filariasis</term><term>Lymphedema</term><term>Orissa</term><term>Professional practice</term><term>Treatment</term><term>Tropical medicine</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Lymphoedème</term><term>Filariose lymphatique</term><term>Lymphangite</term><term>Adénopathie</term><term>Pratique professionnelle</term><term>Traitement</term><term>Orissa</term><term>Médecine tropicale</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The Global Programme to Eliminate Lymphatic Filariasis (GPELF), which includes alleviation of disability and suffering of patients, is implemented primarily in India by primary health care system. The present study assesses the current practices related to lymphoedema care among clinicians of primary healthcare system in three filarial endemic districts of Orissa, India. The results are based on the data obtained through in-depth interviews with 50 clinicians from primary health centres (PHCs) and private clinics located in 22 PHCs sampled from three districts. All clinicians are aware of common as well as atypical manifestations of LF and offered treatment to them. The most commonly dealt complaints are lymphoedema of chronic LF and acute lymphangitis. All the clinicians reported that they prescribed diethylcarbamazine (DEC) for the treatment of patients with acute episodes, and only 50% of them prescribed antibiotics along with DEC. However, there is no uniform pattern either in the dosage of DEC or in the use of antibiotics. In this study, all the clinicians are aware that repeated acute episodes leads to lymphoedema. Majority of clinicians (94%) prescribed DEC to prevent this progression. For reduction of oedema, they offered a variety of treatments and more than half of the clinicians prescribed DEC. The study districts have been covered by the mass drug administration (MDA) of DEC under the GPELF. In order for the GPELF as a whole to prove successful and sustainable, those persons who are already suffering from LF need to be cared for and their suffering is to be relieved. Current practices of clinicians, both at government and private health institutions should be improved. With the revised knowledge that bacterial infections play a key role in the progression of disease, the attitude of clinicians towards the treatment of LF has to be changed.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0001-706X</s0></fA01><fA02 i1="01"><s0>ACTRAQ</s0></fA02><fA03 i2="1"><s0>Acta trop.</s0></fA03><fA05><s2>102</s2></fA05><fA06><s2>3</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India</s1></fA08><fA11 i1="01" i2="1"><s1>KERKETTA (A. S.)</s1></fA11><fA11 i1="02" i2="1"><s1>BABU (B. V.)</s1></fA11><fA11 i1="03" i2="1"><s1>SWAIN (B. K.)</s1></fA11><fA14 i1="01"><s1>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)</s1><s2>Bhubaneswar 751023, Orissa</s2><s3>IND</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ></fA14><fA20><s1>159-164</s1></fA20><fA21><s1>2007</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>3165</s2><s5>354000161628780030</s5></fA43><fA44><s0>0000</s0><s1>© 2007 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>1 p.1/4</s0></fA45><fA47 i1="01" i2="1"><s0>07-0367382</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Acta tropica</s0></fA64><fA66 i1="01"><s0>NLD</s0></fA66><fC01 i1="01" l="ENG"><s0>The Global Programme to Eliminate Lymphatic Filariasis (GPELF), which includes alleviation of disability and suffering of patients, is implemented primarily in India by primary health care system. The present study assesses the current practices related to lymphoedema care among clinicians of primary healthcare system in three filarial endemic districts of Orissa, India. The results are based on the data obtained through in-depth interviews with 50 clinicians from primary health centres (PHCs) and private clinics located in 22 PHCs sampled from three districts. All clinicians are aware of common as well as atypical manifestations of LF and offered treatment to them. The most commonly dealt complaints are lymphoedema of chronic LF and acute lymphangitis. All the clinicians reported that they prescribed diethylcarbamazine (DEC) for the treatment of patients with acute episodes, and only 50% of them prescribed antibiotics along with DEC. However, there is no uniform pattern either in the dosage of DEC or in the use of antibiotics. In this study, all the clinicians are aware that repeated acute episodes leads to lymphoedema. Majority of clinicians (94%) prescribed DEC to prevent this progression. For reduction of oedema, they offered a variety of treatments and more than half of the clinicians prescribed DEC. The study districts have been covered by the mass drug administration (MDA) of DEC under the GPELF. In order for the GPELF as a whole to prove successful and sustainable, those persons who are already suffering from LF need to be cared for and their suffering is to be relieved. Current practices of clinicians, both at government and private health institutions should be improved. With the revised knowledge that bacterial infections play a key role in the progression of disease, the attitude of clinicians towards the treatment of LF has to be changed.</s0></fC01><fC02 i1="01" i2="X"><s0>002B01</s0></fC02><fC02 i1="02" i2="X"><s0>002B12B04</s0></fC02><fC02 i1="03" i2="X"><s0>002B05E03B4D</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Lymphoedème</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Lymphedema</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Linfedema</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Filariose lymphatique</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Lymphatic filariasis</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Filariasis linfática</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Lymphangite</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Lymphangitis</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Linfangitis</s0><s5>03</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Adénopathie</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Adenopathy</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Adenopatía</s0><s5>04</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Pratique professionnelle</s0><s5>09</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Professional practice</s0><s5>09</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Práctica profesional</s0><s5>09</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Traitement</s0><s5>10</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Treatment</s0><s5>10</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Tratamiento</s0><s5>10</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Orissa</s0><s2>NG</s2><s5>11</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Orissa</s0><s2>NG</s2><s5>11</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Orisa</s0><s2>NG</s2><s5>11</s5></fC03><fC03 i1="08" i2="X" l="FRE"><s0>Médecine tropicale</s0><s5>13</s5></fC03><fC03 i1="08" i2="X" l="ENG"><s0>Tropical medicine</s0><s5>13</s5></fC03><fC03 i1="08" i2="X" l="SPA"><s0>Medicina tropical</s0><s5>13</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Nématodose</s0></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Nematode disease</s0></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Nematodosis</s0></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Helminthiase</s0></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Helminthiasis</s0></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Helmintiasis</s0></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Parasitose</s0></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Parasitosis</s0></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Parasitosis</s0></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Infection</s0></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Infection</s0></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Infección</s0></fC07><fC07 i1="05" i2="X" l="FRE"><s0>Inde</s0><s2>NG</s2></fC07><fC07 i1="05" i2="X" l="ENG"><s0>India</s0><s2>NG</s2></fC07><fC07 i1="05" i2="X" l="SPA"><s0>India</s0><s2>NG</s2></fC07><fC07 i1="06" i2="X" l="FRE"><s0>Asie</s0><s2>NG</s2></fC07><fC07 i1="06" i2="X" l="ENG"><s0>Asia</s0><s2>NG</s2></fC07><fC07 i1="06" i2="X" l="SPA"><s0>Asia</s0><s2>NG</s2></fC07><fC07 i1="07" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0><s5>37</s5></fC07><fC07 i1="07" i2="X" l="ENG"><s0>Cardiovascular disease</s0><s5>37</s5></fC07><fC07 i1="07" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0><s5>37</s5></fC07><fC07 i1="08" i2="X" l="FRE"><s0>Lymphatique pathologie</s0><s5>38</s5></fC07><fC07 i1="08" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0><s5>38</s5></fC07><fC07 i1="08" i2="X" l="SPA"><s0>Linfático patología</s0><s5>38</s5></fC07><fN21><s1>239</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard><server><NO>PASCAL 07-0367382 INIST</NO><ET>Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India</ET><AU>KERKETTA (A. S.); BABU (B. V.); SWAIN (B. K.)</AU><AF>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post)/Bhubaneswar 751023, Orissa/Inde (1 aut., 2 aut., 3 aut.)</AF><DT>Publication en série; Niveau analytique</DT><SO>Acta tropica; ISSN 0001-706X; Coden ACTRAQ; Pays-Bas; Da. 2007; Vol. 102; No. 3; Pp. 159-164; Bibl. 1 p.1/4</SO><LA>Anglais</LA><EA>The Global Programme to Eliminate Lymphatic Filariasis (GPELF), which includes alleviation of disability and suffering of patients, is implemented primarily in India by primary health care system. The present study assesses the current practices related to lymphoedema care among clinicians of primary healthcare system in three filarial endemic districts of Orissa, India. The results are based on the data obtained through in-depth interviews with 50 clinicians from primary health centres (PHCs) and private clinics located in 22 PHCs sampled from three districts. All clinicians are aware of common as well as atypical manifestations of LF and offered treatment to them. The most commonly dealt complaints are lymphoedema of chronic LF and acute lymphangitis. All the clinicians reported that they prescribed diethylcarbamazine (DEC) for the treatment of patients with acute episodes, and only 50% of them prescribed antibiotics along with DEC. However, there is no uniform pattern either in the dosage of DEC or in the use of antibiotics. In this study, all the clinicians are aware that repeated acute episodes leads to lymphoedema. Majority of clinicians (94%) prescribed DEC to prevent this progression. For reduction of oedema, they offered a variety of treatments and more than half of the clinicians prescribed DEC. The study districts have been covered by the mass drug administration (MDA) of DEC under the GPELF. In order for the GPELF as a whole to prove successful and sustainable, those persons who are already suffering from LF need to be cared for and their suffering is to be relieved. Current practices of clinicians, both at government and private health institutions should be improved. With the revised knowledge that bacterial infections play a key role in the progression of disease, the attitude of clinicians towards the treatment of LF has to be changed.</EA><CC>002B01; 002B12B04; 002B05E03B4D</CC><FD>Lymphoedème; Filariose lymphatique; Lymphangite; Adénopathie; Pratique professionnelle; Traitement; Orissa; Médecine tropicale</FD><FG>Nématodose; Helminthiase; Parasitose; Infection; Inde; Asie; Appareil circulatoire pathologie; Lymphatique pathologie</FG><ED>Lymphedema; Lymphatic filariasis; Lymphangitis; Adenopathy; Professional practice; Treatment; Orissa; Tropical medicine</ED><EG>Nematode disease; Helminthiasis; Parasitosis; Infection; India; Asia; Cardiovascular disease; Lymphatic vessel disease</EG><SD>Linfedema; Filariasis linfática; Linfangitis; Adenopatía; Práctica profesional; Tratamiento; Orisa; Medicina tropical</SD><LO>INIST-3165.354000161628780030</LO><ID>07-0367382</ID></server></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000452 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000452 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:07-0367382
|texte= Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India
}}
| This area was generated with Dilib version V0.6.31. |  |